A Partnership Between Physicians and TheirCommunity
Maryland Oncology Hematology believes in providing patients with advanced, comprehensive cancer therapies in a community setting that allows patients to receive care near their support systems. Our highly trained and experienced physicians work closely with a talented clinical team that is sensitive to the needs of cancer patients and their caregivers. Choosing an independent practice offers patients the chance to receive compassionate, affordable cancer care that utilizes the latest technologies provided by top physicians who are experts in their field. The best of care, close to home.
Patients can be assured that as an independent practice, MOH physicians are able to send patients to the best specialists or make recommendations based on specific care needs. We are never beholden to a practice or network. Unlike some of the major hospitals, our doctors are focused solely on oncology, giving patients the expert care that they deserve. At Maryland Oncology Hematology, we believe that patients are more than a number. Each patient will have a dedicated care team by their side from diagnosis through treatment to recovery.
Maryland Oncology Hematology is a community-based practice, entirely owned and run by Maryland physicians. Our team is devoted to providing state-of-the-art patient care for hematology and oncology, working on behalf of our community for the benefit of patients.
“I’m excited to be part of this highly respected community-based private practice,” said Jason Taksey MD., medical oncologist and managing partner for new Annapolis location. “Maryland Oncology Hematology delivers state-of-the-art care and remarkable treatments in an outpatient center that is safe, modern, convenient, and responsive to patient feedback.”
Why Patients Trust MOH
Comprehensive care including new radiation oncology services offered at White Oak Cancer Center in Silver Spring
Top-Rated Breast and Colorectal Surgeons
Team of almost 50 physicians and more than 50 years of experience
Research and phase 1-3 drug trial participation
Support groups and education
Choosing an Independent Cancer Provider
As an independent practice, Maryland Oncology Hematology is proud to offer patients increased access to integrated, evidence-based cancer care and clinical research throughout the communities of Maryland. When compared to oncology services at big hospitals, independent cancer centers are typically more conveniently located, more individualized, and more likely to offer all necessary services under one roof. Independent cancer centers are also more cost effective for patients.
At MOH, our state-of-the-art infusion centers offer a full range of chemotherapy services, laboratory testing, clinical trials, and support services, provided by people who have an unwavering commitment to achieving the best possible result.
Our providers also have the freedom to choose the best possible specialists and hospital services for our patients, as well as arranging referrals for additional consultation or specialty care when needed. We ensure that our patients receive the best care based on each person’s unique diagnosis and treatment needs.
Maryland Oncology Hematology is able to offer cutting edge and innovative clinical research trials without the delays that many hospitals face. In partnership with US Oncology Network, MOH is able to unite the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients. These independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes.
Benefits to Patients
At Maryland Oncology Hematology, we strive to help patients through positive patient-doctor relationships while utilizing the latest in advanced technology. Other benefits include:
Better Access and Convenience
Community facilities offer integrated care close to home meaning there is less travel for patients. This provides reduced ER visits, admissions, and overnight hospital stays because of the proximity to care. At community cancer care clinics, patients receive treatments from one care team. In the hospital setting, patients are likely to see a different doctor and nurse throughout treatment.
Our team utilizes a multidisciplinary approach to cancer care, combined with the most advanced treatments, cutting-edge technologies, and clinical trials research program. This includes precision medicine based on the genetic profile of a patient or their specific diseases. Molecular testing can be used to help target cancer treatments, as well as improve accuracy of a diagnosis in complex cases or help patients learn if there is a risk of cancer that runs in their families.
At Maryland Oncology Hematology, we offer immediate appointments to newly referred patients, ensuring they get the care they need without stressful and unnecessary delays they might otherwise experience in major hospital systems. Our team will schedule a consult with one of our experts who can provide guidance and treatment options, as well as address any patient and family member concerns.
Community care offers patients:
Shorter wait times
Easily accessible surface parking and patient drop-offs
Less likelihood of catching infection associated with hospital visits
Access to support services, including social workers, financial assistance, and reimbursement specialists
Access to groundbreaking clinical trials
Lower cost of care across all cancer types when compared to hospital settings
“We’re grateful to have the privilege to bring remarkable cancer care advances to our patients, as well as offer therapies that can improve their quality of life,” said Dr. Jason Taksey. “At MOH Annapolis, we are excited to offer superior care options for our patients and our surrounding community.”
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland with locations in Annapolis, Bethesda, Brandywine, Clinton, Columbia, Frederick, Germantown, Lanham, Laurel, Mt. Airy, Rockville and the White Oak Cancer Center in Silver Spring. Our more than 40 physicians are devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. For more information, visit MarylandOncology.com.
Every aspect of the Coronavirus disease 19 (COVID-19) pandemic has occurred at record speeds, from disease transmission to vaccine development. COVID-19, caused by a novel coronavirus known as SARS-CoV-2, targets the respiratory system. Most people experience flu-like symptoms; however, in the elderly and those with comorbidities, mild respiratory issues can quickly progress to Acute Respiratory Distress Syndrome, resulting in multiple organ failure and death.
The highly contagious nature of this virus, which is spread through droplets and aerosols released when an infected person sneezes or coughs, is evident by the fact that over 106 million COVID-19 cases have been reported worldwide. Over 2.35 million people have already succumb to the virus1–3.
The limitations of hospital capacity, ventilators, and healthcare personnel have been constant concerns throughout this pandemic. Worldwide regulations promoting social distancing and hygiene have prevented transmission, but they have also crippled the economy and stifled social freedoms1,2.
The overwhelming nature of this pandemic has led to the development of COVID-19 vaccines within an unprecedented timeframe. Despite the relief that this brings to some, many are concerned about the effects of the vaccine. A poll conducted by The Associated Press-NORC Center for Public Affairs research reported that of the 20% of Americans that did not want the COVID-19 vaccine, 70% were concerned about side effects4. Furthermore, the speed with which the COVID-19 vaccines were developed have left many questioning whether proper precautions and protocols are still being implemented. The Food and Drug Association (FDA) has stated that vaccine production will be in accordance with legal and regulatory guidelines5.
A cancer patient, who’s immune system is likely compromised by the effects of chemotherapy, would be understandably concerned about the virus and possible risks associated with the vaccine. This article aims to provide insight into the COVID-19 vaccine, concerns for cancer patients, and recommendations of healthcare professionals.
The COVID-19 vaccine: development, efficacy, and side effects
A vaccine is considered effective when it reduces the infection rate, disease severity, or disease transmission. One of the main goals of a vaccination strategy is to create herd immunity, which is a large population of people that are immune to a specific disease6. With the aid of new vaccine development technologies, human clinical trials for the first potential COVID-19 vaccine began on March 16th 2020, just 4 months following the outbreak7. On February 10th 2021, the New York Times Coronavirus Vaccine Tracker reported that 69 COVID-19 vaccines were in the human clinical trial phase8.
Vaccine development was previously a 10-15 year process, and had the COVID-19 vaccines been made in this manner, scientists would still be the exploratory phase of the development process9. Soon after the COVID-19 outbreak in China, scientists unraveled the genetic code for SARS-CoV-2, which serves as the blueprint for the virus’s structure10.Then, by studying the virus’s structure, a protein called the spike protein was found on the outer surface of SARS-CoV-2. Researchers found that SARS-CoV-2 uses the spike protein to bind to and enter human cells, where it can replicate and cause sickness11. The spike protein is now the main target for COVID-19 vaccines12.
Traditionally, vaccines contained a weak or inactivated form of a virus that would allow the body to trainagainst a weakened opponent so it would be better prepared to fight the same virus during an actual infection13. The COVID-19 vaccine was developed using RNA technology, an idea that was introduced in the 90’s by French researchers14. An RNA vaccine contains an mRNA sequence, which is simply a refined version of the blueprint used to build a particular protein. Once in the body, cells can process this code to produce the protein. If this is a viral protein, the body recognizes it as foreign, and the immune system is trained to eliminate it. Some COVID-19 vaccines introduce the code for the spike protein so that the body will be trained to fight it when presented with the actual virus13. Two of the leading COVID-19 vaccines, BNT162b2 Pfizer-BioNTech and mRNA-1273 Moderna, which have been approved for emergency use in the U.S. and E.U., are mRNA vaccines that target this spike protein8,15. COVID-19 vaccines may require periodic updates, similar to the Influenza vaccine, in order to accommodate mutations16.
The Centers for disease control and prevention (CDC) reports a 94.1% efficacy with the Moderna vaccine based on 1 large Phase III clinical trial with 30,000 participants aged 18-95 that had not previously tested positive for COVID-19. Systemic adverse effects, described as mild to moderate, were more common after the 2nd dose. These effects were more severe in patients under 6517. Pain, swelling, and redness were reported as localized reactogenicity symptoms, while chills, fatigue, and headaches were listed as systemic adverse effects18. The World Health Organization (WHO) reported that the Moderna vaccine is safe in patients with comorbidities, such as hypertension or diabetes, and chronic infections, provided that their condition is stable and controlled. Due to the possibility of severe allergic reactions, vaccinees must be monitored for 15 minutes after administration. They also report that the effect on immunocompromised people has not been properly investigated. Persons who have previously tested positive for COVID-19 are not deterred from getting vaccinated, but are advised to wait 6 months19.
Both the Moderna and Pfizer vaccine require 2 doses for maximal efficacy. The New England Journal of Medicine reported 95% efficacy in persons that received both doses of the Pfizer vaccine and 52% efficacy is expected after the 1st dose20. A recent report from Israel described a 33% reduction in COVID-19 cases after the first dose. It is important to consider that the Israeli report is based on persons over 60 years, whereas the original Pfizer study included young people as well21. The Pfizer Emmergency Use Authorization Fact Sheet reports similar side effects to that of Moderna, and immunocompromised patients are asked to report their conditions beforehand22.
The COVID-19 vaccine: considerations for cancer patients
Due to the heterogeneity in cancer patients, there has been some debate as to whether they should be considered a high-risk group. Morbidity and mortality rates between 5 and 61% have been reported in cancer patients that contract COVID-1923. The immunosuppressive effect of many cancer treatments make cancer patients more susceptible to infection. One literature review reported that 10/11 studies in COVID-19 patients reported higher fatalities in patients that also had cancer, especially hematological cancers. Such data argues that cancer patients should be also receive priority vaccination23,24.
Data concerning the effect of the COVID-19 vaccine in cancer patients is very scarce. Of the nearly 44,000 participants in the Pfizer clinical trial only 3.7% were cancer patients23. The immunosuppression in cancer patients caused by chemotherapy, radiation, and/or targeted therapy is also expected to reduce the efficacy of the vaccine. The goal of a vaccination is to elicit an immune response that will train the immune system to fight against a particular disease. A weakened immune system is less likely to respond to this challenge and may therefore be incapable of being trained25. Some have tried to compare the COVID-19 vaccine to the Influenza vaccine; however, studies reporting the vaccine efficacy in cancer patients who received the flu vaccine show that the outcome depends on the cancer type and treatment26–28.
Dr. Nora Disis, a medical oncologist and the director of the Institute of Translational Health and the Cancer Vaccine Institute at the University of Washington, suggests that vaccine dosage and the timing are points of concern, especially in patients in active treatment. She also suggested that cancer patients avoid vaccinations containing an active form of the virus as this could lead to infection in immunocompromised patients29.
Recommendations and reminders for cancer patients
Currently, no COVID-19 vaccines containing live virus have been approved for administration, therefore there should be no risk of becoming infected by the vaccine itself29. As studies of the vaccine in cancer patients are lacking, it is uncertain if cancer patients are susceptible to side effects other than those reported in the general population. The overall recommendation for cancer patients is to receive the vaccine as the risk of contracting the virus is far greater than the possibility of the vaccine being less effective30. We recommend that patients actively on treatment discuss with their oncologist the timing of vaccine administration.
Dr. Jeffrey Farma, a surgical oncologist at the Fox Chase Cancer Center in Pennsylvania, recommends that cancer patients with upcoming surgeries schedule enough time between surgery and the vaccination. Furthermore, patients that have undergone a bone marrow transplant should consult with their hematologist to determine when their immune system will be able to respond to the vaccine. All cancer patients or survivors should consult with their physicians before getting vaccinated31.
Time will tell if current COVID-19 vaccines provide long-term protection and whether they are effective against new variants. Therefore, the advice given to all vaccination recipients is to continue adhering to social distancing and hygiene regulations. Cancer patients, especially, should continue to protect themselves from unnecessary exposure to COVID-19 and any other diseases32,33.
Dr Juneja joins Maryland Oncology Hematology’sWhite Oak Cancer Center after 13 years of practice in Northern Virginia and Bethesda. He has subspecialized in breast, gastrointestinal, lymphoma, and myeloma in his prior practices. He is very interested in clinical research and cutting edge as well as precision medicine. Previously, he has designed clinical trials with Bristol Myers Squibb, been a medical officer at the FDA, and has been an investigator in several clinical trials.
Having survived cancer himself, he completely understands what it is like to be a patient. He lives with his wife, 2 children, dog, and enjoys playing piano, tennis, running, bicycling, and sailing.
Yuki, K., Fujiogi, M. & Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clinical Immunology vol. 215 108427 (2020).
Singhal, T. A Review of Coronavirus Disease-2019 (COVID-19). Indian Journal of Pediatrics vol. 87 281–286 (2020).
COVID-19 situation update worldwide, as of week 5, updated 11 February 2021. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.
Expectations for a COVID-19 Vaccine – AP-NORC. https://apnorc.org/projects/expectations-for-a-covid-19-vaccine/.
Shah, A., Marks, P. W. & Hahn, S. M. Unwavering Regulatory Safeguards for COVID-19 Vaccines. JAMA – Journal of the American Medical Association vol. 324 931–932 (2020).
Hodgson, S. H. et al. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. The Lancet Infectious Diseases vol. 21 e26–e35 (2021).
Le, T. The COVID-19 vaccine development landscape. doi:10.1038/d41573-020-00073-5.
Zimmer, C., Corum, J. & Wee, S.-L. Covid-19 Vaccine Tracker Updates: The Latest – The New York Times. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html.
Government Accountability Office, U. GAO-20-583SP, Science & Tech Spotlight: COVID-19 Vaccine Development.
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature579, 270–273 (2020).
Ou, X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun.11, 1–12 (2020).
Mahase, E. How the Oxford-AstraZeneca covid-19 vaccine was made. The BMJ vol. 372 (2021).
RNA vaccines: an introduction | PHG Foundation. https://www.phgfoundation.org/briefing/rna-vaccines.
Dolgin, E. How COVID unlocked the power of RNA vaccines. Nature589, 189–191 (2021).
Dai, L. & Gao, G. F. Viral targets for vaccines against COVID-19. Nature Reviews Immunology vol. 21 73–82 (2020).
Callaway, E. & Ledford, H. How to redesign COVID vaccines so they protect against variants. Nature590, 15–16 (2021).
Oliver, S. E. et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020. MMWR. Morb. Mortal. Wkly. Rep.69, 1922–1924 (2020).
Information about the Moderna COVID-19 Vaccine | CDC. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html.
The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know. https://www.who.int/news-room/feature-stories/detail/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know?gclid=Cj0KCQiAyJOBBhDCARIsAJG2h5fDy4YPD3cz69Fqiff3ooH4F3065k93kC60SksUGHs-gU62LA16z38aAi6ZEALw_wcB.
Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med.383, 2603–2615 (2020).
Mahase, E. Covid-19: Reports from Israel suggest one dose of Pfizer vaccine could be less effective than expected. BMJ372, n217 (2021).
Inc, P. Pfizer COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers. www.cvdvaccine.com.
Ribas, A. et al. Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited. Cancer Discov.11, 233–236 (2021).
ASH-ASTCT COVID-19 and Vaccines: Frequently Asked Questions – Hematology.org. https://www.hematology.org/covid-19/ash-astct-covid-19-and-vaccines.
Yap, T. A. et al. SARS-CoV-2 vaccination and phase 1 cancer clinical trials. Lancet Oncol.0, (2021).
Ayoola, A. et al. Efficacy of influenza vaccine (Fluvax) in cancer patients on treatment: a prospective single arm, open-label study. Support. Care Cancer28, 5411–5417 (2020).
Zhang, L. et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann. Oncol.31, 894–901 (2020).
Yri, O. E. et al. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood118, 6769–6771 (2011).
COVID-19 Vaccines and Cancer Patients: 4 Things to Know. https://www.medscape.com/viewarticle/942907.
COVID-19 Vaccines and Cancer. https://news.cancerconnect.com/treatment-care/covid-19-vaccines-and-cancer-FQLL1FPx7kyOUcSjmR2JNQ.
COVID-19 Vaccines: Here is What Cancer Patients and Survivors Need to Know Now | Fox Chase Cancer Center – Philadelphia, PA. https://www.foxchase.org/blog/covid-19-vaccines-here-is-what-cancer-patients-and-survivors-need-to-know-now.
What cancer patients need to know about COVID-19 vaccines | CTCA. https://www.cancercenter.com/community/blog/2020/12/covid-vaccine-cancer-patients.
Oncologists can allay COVID-19 vaccination concerns of patients with cancer, survivors. https://www.healio.com/news/hematology-oncology/20210208/oncologists-can-allay-covid19-vaccination-concerns-of-patients-with-cancer-survivors.
Did you know that eating a healthy, balanced diet is an important way to protect yourself from cancer? Putting the right kinds of food into your body can provide you with the vitamins, minerals, and nutrients to keep you healthy and strong. To help build your defense against cancer, focus on eating some of these cancer-fighting foods that may already be in your kitchen.
Foods That Help Fight Cancer
The National Cancer Institute does not recommend any dietary supplement for the prevention or treatment of cancer. However these foods have shown potential for reducing the risk of developing cancer due to their cancer-fighting properties.
Leafy Green Vegetables
Leafy green vegetables are loaded with vitamins, minerals, and enzymes, while remaining very low in calories, sodium, and fat. Greens such as spinach, kale, collard greens, swiss chard, leaf lettuce, and romaine lettuce, are known to combat a variety of cancers including skin cancer, breast cancer, stomach cancer, and breast cancer. Because they are also rich in carotenoids, the plant pigments that act as antioxidants in the body, leafy greens are also thought to be good at battling cancers of the mouth, pharynx, and larynx.
Cruciferous vegetables such as broccoli, cauliflower, cabbage, brussels sprouts, radishes, and even wasabi, contain fiber, folate and vitamins C, E, and K. They also get their strong smell and bitter flavor from substances known as glucosinolates, which are sulfur-containing chemicals. Adding vegetables like these to your diet can help boost your body’s protective enzymes and flush out cancer-causing chemicals.
Cruciferous veggies are considered to be most useful in reducing the risk of developing bladder cancer, stomach cancer, liver cancer, lung cancer, prostate, skin cancer, and breast cancer.
Garlic is a staple ingredient that has been used for both culinary and medicinal purposes around the world. Protective effects from garlic may arise from its antibacterial properties or from its ability to block the formation of cancer-causing substances, enhance DNA repair, reduce cell proliferation, or induce cell death. Garlic is most useful in fighting against breast cancer, pancreatic cancer, esophageal cancer, and stomach cancer.
Most people take garlic in the form of a supplement rather than eating bulbs of garlic. The World Health Organization’s (WHO) guidelines for general health promotion for adults is one of the following:
a daily dose of 2 to 5 g of fresh garlic (approximately one clove)
0.4 to 1.2 g of dried garlic powder
2 to 5 mg of garlic oil
300 to 1,000 mg of garlic extract
or other formulations that are equal to 2 to 5 mg of allicin
While tomatoes are an excellent source of vitamins C and A, it’s the lycopene, the pigment that gives red tomatoes their color, that has been studied for its cancer-fighting effects. Antioxidants, such as lycopene, destroy damaging free radicals, which can attach your your cells and hurt your immune system. Although the evidence suggests that foods containing lycopene, including tomatoes, likely offer cancer protection, the American Institute for Cancer Research stresses the importance of eating a variety of plant foods. No single food can effectively lower cancer risk, so it is important to eat a variety of healthy foods so you can gain the most benefit in fighting cancer.
Lycopene in tomatoes is believe to be most helpful in fighting endometrial cancer, lung cancer, prostate cancer and breast cancer.
Raspberries, blackberries, strawberries, blueberries, and berries of every color are good sources of vitamin C and fiber. They are also rich in antioxidants and ellagic acid, which help block free radicals and deactivate specific carcinogens (cancer causing agents) that can lead to cancer growth. Berries have been found to be useful in fighting colorectal cancer, esophageal cancer, skin cancer, and oral cancer.
These are just a handful of foods that will help you maintain an overall healthy diet which is recommended to fight cancer. To learn more about what foods make for healthy choices, you can visit the American Cancer Society’s Basic Ingredients for a Healthy Kitchen. Consume all things in moderation, even healthy foods, and include a wide variety of healthy foods in your daily intake, not just those listed here.
Foods That Can Cause Cancer
Not all meats and dairy products are bad for you, however, the ones that contain saturated fats can be. Consider choosing low-fat versions of meats and cheeses, and steer clear of processed meats whenever you can which tend to be higher in fat, nitrates and other preservatives.
The less alcohol you drink, the lower the risk of cancer. It doesn’t matter whether it’s beer, wine, or spirits–too much alcohol can impair your body’s ability to fight disease. The National Cancer Institute recommends that women have no more than one drink per day and men have no more than two drinks per day. Excessive alcohol consumption can put you at an increased risk of mouth cancer, esophagus cancer, breast cancer, and liver cancer.
When high-temperature methods, such as grilling, are used to cook meats like beef, pork, fish, and poultry, certain DNA-damaging chemicals, called HCAs and PAHs can form. Although it is still unclear whether such exposure causes cancer in humans, the cancer that it has been found to cause in animals indicates that it may be best to avoid foods that are highly charred (black from heat exposure).
There are many other foods that researchers are still studying to determine whether they may contribute to the development of cancer or help reduce your risk of cancer. If you have questions regarding how to prevent cancer, it’s best to consult your doctor. The team at Maryland Oncology Hematology is always ready to help patients find healthy food options they can enjoy both now and after cancer treatment. For more information,contact us, or visit us at one of our 12 locations including Annapolis, Bethesda, Brandywine, Clinton, Columbia, Frederick, Lanham, Laurel, Mt. Airy, Rockville at Aquilino Cancer Center and Silver Spring at White Oak Cancer Center.
For more information on cancer prevention you can visit the following blogs:
Dr. Magnant joins Dr. Surupa Sen Gupta at their Rockville Division to offer the community advanced surgical care with the latest breast preservation techniques.
Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, is proud to announce that Dr. Colette Magnant, MD, FACS is joining its Rockville division.
Dr. Magnant has been treating breast cancer for over 34 years and has established herself as one of the premier breast cancer surgeons in the Washington, D.C. metropolitan area. With her extensive training and wealth of experience, she provides her patients with a superior understanding of breast cancer biology, as well as compassionate state of the art breast preservation procedures, and advanced surgical techniques. She will be joining Dr. Surupa Sen Gupta to expand our breast surgical oncology services at our Rockville division, and together they, along with our expert and experienced medical oncologists, will anchor our comprehensive breast cancer program in the Rockville division.
‘We’re thrilled to welcome Dr. Magnant to our experienced breast surgical team. Her stellar reputation as a top breast surgeon is well-deserved and we are fortunate that she has decided to bring her skills to our practice and to our community. She shares our vision of providing state-of-the-art multidisciplinary cancer care, and we are delighted to have her join in our expansion said George Sotos MD, Managing Partner, Rockville Division. ‘With her focus and strong surgical experience in breast cancer treatment, Dr. Magnant is a welcome addition to our team as we dedicate our practice to delivering the very best in comprehensive and integrated care to our breast cancer patients.
Dr. Magnant is board certified in general surgery, specializing in advanced breast surgery techniques, including skin and nipple-sparing mastectomies and minimally invasive breast conserving surgeries. After earning her medical degree from the Medical College of Virginia in Richmond, Dr. Magnant completed her general surgery internship at Indiana University Medical Center and her residency at Georgetown University Hospital in Washington, DC. She is most recently the past director of the Sullivan Center for Breast Health at Sibley Hospital, as well as an assistant professor at John Hopkins University. In addition to teaching, Dr. Magnant has made numerous media appearances and delivered dozens of university lectures.
‘I’m proud to work alongside the dynamic team at Maryland Oncology Hematology, said Dr. Magnant. ‘We’re dedicated to delivering compassionate and comprehensive breast health services to the surrounding community, allowing our patients to receive the best of care, close to home.
Dr. Magnant will be joining Dr. Sen Gupta who is board certified in general surgery, fellowship trained in breast surgical oncology, and specializes in minimally invasive breast-conserving surgeries.
Dr. Magnant will start seeing patients at MOH’s Rockville office on April 1st. Appointments are available for newly referred patients to provide a high level of support and easy access to care. Please call 301.424.6231 to make an appointment.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation , whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. MOH also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
Media Contact Company Name: Maryland Oncology Hematology Contact Person: Mark W Lamplugh Jr Email: Send Email Phone: 5617629729 Country: United States Website: https://marylandoncology.com
A study published in the Journal of the National Cancer Institute made headlines for its startling and mysterious conclusion: The incidence of colorectal cancer in young adults has increased sharply in generations born after 1950. Individuals born in the 1990s (currently age 18 to 27) are twice as likely to develop colon cancer and four times as likely to develop rectal cancer than individuals born in the 1950s were at those ages.
Why is this type of cancer suddenly on the rise in younger adults? No one knows for certain. Researchers suspect changes in diet, more sedentary lifestyles, and obesity could be contributing factors. Another theory is that cancers are simply being detected much earlier than in past decades.
What Is Colorectal Cancer?
Colorectal cancer refers to cancer that begins in the colon or rectum, which together make up the large intestine. Sometimes they are referred to individually as colon cancer or rectal cancer. Most colorectal cancers begin with a polyp that develops on the inner lining of the colon or rectum. The two primary types of polyps are adenomas, which are most likely to become cancer, and hyperplastic and inflammatory polyps, which are more common but far less likely to become cancerous.
Polyps are common in people age 50 and older. Most aren’t cancerous. If a polyp does become cancerous, cancer cells can eventually spread to the wall of the colon or rectum. From there, they can spread to the blood or lymph vessels of the colon or rectum and eventually spread to lymph nodes and metastasize throughout the body.
Colorectal Cancer: Signs and Symptoms
As with many cancers, colorectal cancers sometimes occur with minimal — or no — symptoms. More often than not, though, this cancer is associated with telltale signs. If you know what to watch for, you’ll know if and when it’s time to schedule a colorectal screening to rule out cancer. If you develop any of the following symptoms, consult your doctor right away. It’s better to be safe than sorry!
Any indication of blood on or in the stool.
Cramps, gas or unusual stomach pain that persists.
Unexplained weight loss.
Constipation, diarrhea, bowel incontinence or other unusual bowel habits.
Feeling that your bowel isn’t emptying completely.
How to Reduce Your Risk of Developing Colorectal Cancer
According to the American Cancer Society, there is no way to definitively prevent colon cancer — or most cancers, for that matter. Some of the main risk factors for developing colorectal cancer — family history, advanced age and history of inflammatory bowel disease — aren’t within your control.
Others risk factors are within your control. Doctors recommend taking the following steps to reduce your risks:
Maintaining a healthy weight and avoiding excess weight around your midsection.
Participating in regular moderate exercise.
Increasing your intake of fruits and vegetables and limiting red and processed meats.
Avoiding excess alcohol consumption.
Screening Is The Most Powerful Preventive Tool
Arguably, the most effective way to reduce the likelihood that you’ll develop colorectal cancer is to undergo regular colorectal cancer screening to detect cancerous or precancerous cells in the absence of other symptoms.
It takes about a decade for precancerous cells to form polyps. Screenings can detect precancerous polyps, so they can be removed before they become cancerous, and can detect cancerous polyps early when the cancer is curable.
Colorectal screening methods include fecal blood tests and colonoscopy. During a colonoscopy, a flexible tube with a viewing lens and tissue removal tool is inserted into the colon. A physician checks the colon lining for growths and can remove any abnormal growths detected.
Current guidelines recommend that most individuals consider a screening colonoscopy at age 50 — earlier for those with a family history of the disease talk to your physician about the best choice for your situation.
Complementary therapies are products and/or practices that differ from standard medical care provided by your oncologists. These non-traditional methods are in no way meant to replace cancer treatment. They’re called complementary because they are meant to work alongside your cancer treatment in hopes of relieving symptoms and side effects, relieving pain, and improving quality of life.
Complementary therapies typically concentrate on relaxation and reducing stress. Many of these types of therapies may help calm emotions, relieve anxiety, reduce nausea, minimize pain, provide extra energy, and increase overall health and well being.
Many cancer patients feel as though complementary therapies leave them with a little more control over their health as they go through cancer treatment. They also tend to appreciate that complementary therapies do not require additional medicines. When the symptoms and side effects of your cancer treatment are difficult to cope with, these alternative approaches can be supportive in bringing relief. Before adding any complementary therapy to your current treatment, however, it is important to talk with your cancer specialist.
There are many different types of complementary therapy. Be sure to tell your therapist or instructor that you are a cancer patient before you start any complementary therapy. This is important information that could impact what they recommend for you.
Complementary therapies include, but are not limited to:
Aromatherapy and Essential Oils: The use of essential oils either by inhalation or topical application. Oils can aid in reducing anxiety, nausea, depression, and pain. Be sure you receive instruction before applying any oils to your skin.
Acupuncture: The practice of applying needles, heat, pressure, and other treatments to one or more places on the skin known as acupuncture points. It can be effective for cancer treatment side effects such as nausea and vomiting, pain, and fatigue.
Chiropractic: A chiropractor can provide hands-on manipulation of the spine (adjustment) that can help with stresses cancer treatment has put on the musculoskeletal system, which can increase mobility, flexibility, strength, and function. It may also help relieve nausea, fatigue, headaches, and other body pains in the back and neck area.
Herbal supplements: May help strengthen the immune system and ease the side effects of cancer treatment. These can interact with medicines being used for cancer treatment and should always be discussed with your cancer care team before using.
Massage therapy: A hands-on method of manipulating the soft tissues of the body that can promote relaxation and help with pain, fatigue, immune function.
Art or music therapy: Creative arts that promote a better quality of life by aiding in the reduction of depression, anxiety, and pain. It can also be a positive outlet for emotional expression.
Yoga: Yoga connects the mind and body through movement and meditation. Yoga can help improve quality of life by relieving both physical and emotional stress.
Support groups: Group meetings can help cancer patients cope. Having emotional support can help improve both quality of life and survival.
In most cases, cancer doctors are very supportive of their patients using complementary therapies. This is typically because they have seen people cope better with the cancer and its treatment.
Again, it isn’t recommended that complementary therapies replace cancer treatment. They are simply meant to be used in conjunction with the current cancer treatment. Talking with your cancer specialist can help find the right balance between the complementary therapies and traditional treatments you are receiving for your cancer. Our oncologist at Maryland Oncology Hematology are able to talk you through these complementary cancer therapies, as well as additional methods of therapy that may be best for your cancer care. If you are in Maryland or the Washington D.C. area, you can schedule a consultation by picking the Maryland Oncology Hematology location that’s most convenient to you and calling to make an appointment.
Check our 2/19/2021 weather update page for practice closures and operating hour changes for tomorrow. All recent updates will be added or changed as offices make decisions. If your office isn’t listed, then no changes have be made yet. Feel free to call your office with any questions regarding appointments. Check this page for updates throughout the evening and tomorrow.
Columbia office will be open normal business hours.
Capital division which includes Silver Spring White Oak Cancer Center & Laurel will be open normal hours.
Our Southern division which includes Brandywine & Lanham will be open 1 hour late on 2/19/2021
Our Frederick division which included our Frederick & Mt Airy office will open at 10AM 2/19/2021
Rockville Division which includes Rockville – Aquilino Cancer Center, Germantown and Bethesda will be open at 10AM on 2/19/2021
Annapolis will open at 10AM on 2/19/2021 due to the weather.
For American women, breast cancer is the second most commonly diagnosed cancer after skin cancer. On average, one in eight women and one in 1,000 men will be diagnosed with breast cancer during their lifetime.
Thanks to breast cancer awareness initiatives launched by charities including Susan G. Komen for the Cure and the Breast Cancer Research Foundation, most U.S. women and men know that if they, or a loved one, discover a lump in their breast, they should be screened for breast cancer. You may be surprised to learn there’s a type of breast cancer called inflammatory breast cancer, accounting for less than 5% of all cases, that doesn’t develop a lump. Instead, this type of cancer blocks the lymph vessels, causing fluids to back up and generating unusual symptoms including persistent breast itching, nipple discharge, and a mark that looks like an insect bite that doesn’t go away.
Beyond the Lump: Lesser Known Breast Cancer Warning Signs
The more familiar you become with your breasts, the more likely you’ll be to notice changes. While lumps sometimes form deep within breast tissue (meaning in the early stages they can only be detected by a mammogram), other breast cancer red flags occur on the surface of the breast. They’re easily detectable – if you know what to look for. Here are six symptoms to watch for. If you detect one or more, you should be evaluated as soon as possible by a qualified physician.
Warm, red, irritated and/or itchy breasts. These are among the most common early warning signs of inflammatory breast cancer.
Nipple discharge. With the exception of breast milk that may leak from breasts during or after pregnancy, any nipple discharge should be checked by a doctor. Clear or bloody discharge may indicate cancer.
Flat or inverted nipple. If this is unusual for you, have it evaluated by a doctor.
Scaliness. Healthy breast skin is smooth. If yours is scaly or inflamed, that’s a red flag.
Changes in skin texture. If you develop a rash, puckering or dimpling on the breast, that could be a sign of breast cancer. Skin changes related to breast cancer may resemble the rough skin of an orange peel.
Change in breast size or shape. While it’s not uncommon for someone to have one breast that’s larger than the other, any new change in breast size or shape, including swelling or shrinkage, could indicate cancer.
Knowing what breast cancer red flags to watch for is important, but so is knowing about breast changes that may be completely normal. Throughout a women’s menstrual cycle, periodic breast pain, tenderness and heaviness is common. If you experience these feelings in both breasts, and are menstruating or about to begin your cycle, these symptoms are most likely the result of normal, monthly hormonal changes in your body. For more information about what’s normal and what’s not, check the blog about common breast cancer myths.
When in Doubt, Get Checked Out
If you’re experiencing any of the symptoms mentioned above, or if you’re having pain at times other than the start of your menstrual cycle, it would be a good idea to talk to your doctor about getting a mammogram. There’s no need to panic. Schedule an appointment with your gynecologist, who will typically examine you and then refer you for a mammogram. Mammograms effectively detect 84% of breast cancers; so when you’re given a clean bill of health you can set your mind at ease. If your mammogram detects a suspicious mass, you may need to be evaluated further. If you do have breast cancer, you can expect a better outcome, because the earlier cancer treatment begins, the better patient outcomes usually are. If you live in Maryland, Washington, D.C. or the surrounding areas and want to be examined by a breast cancer specialist, contact us at Maryland Oncology Hematology.
Due to weather our Frederick & Mt Airy offices will be opening 10AM on 2/2/2021. If you have questions regarding rescheduling, you can reach our Frederick office at 301-695-6777 and Mt Airy at 301-829-0707.